PACOME (PAtient Cancer Oral MEdication) Cohort of Patients Treated With Oral Anticancer Drugs Benefiting From Oncoral Multidisciplinary Monitoring in Real Life: Predictive Factors and Safety of Treatments

Imagine you're taking your cancer medicine at home instead of having to go into the hospital for injections. This is becoming more common, and many people prefer it because it gives them more freedom and means less time spent in a hospital. However, taking strong medications at home means we need to be extra careful that everything goes smoothly and safely. Sometimes, managing these medicines at home can be tricky, and there's a small risk of problems with the medication or its side effects.

That's where the Oncoral programme comes in. It's a special support system set up to help patients taking oral cancer drugs at home. A team of experts, including your cancer doctor, a pharmacist, and a nurse, work together. They also connect with your local doctor (GP), community pharmacist, and any nurses who visit you at home. This team helps educate you about your medicine, answers your questions, and makes sure any problems are quickly dealt with. They focus on what's important to you, your quality of life, and any difficulties you might face.

The PACOME study is looking at patients who are part of this Oncoral programme. It collects information about their experiences, how well their treatment works, and how their care is organised. By gathering all this information, researchers hope to learn more about how oral cancer treatments work in real-world settings, outside of clinical trials. This will help them understand how to make these treatments safer and more effective, and how to improve the way support is given to patients taking these types of medicines at home. Ultimately, the goal is to develop better care plans for everyone.